Cyclacel Pharmaceuticals Inc (CYCC)
1.51
-0.09
(-5.62%)
USD |
NASDAQ |
Apr 26, 16:00
1.51
0.00 (0.00%)
After-Hours: 20:00
Cyclacel Pharmaceuticals Total Liabilities (Quarterly): 8.198M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.198M |
| September 30, 2023 | 8.20M |
| June 30, 2023 | 6.812M |
| March 31, 2023 | 7.418M |
| December 31, 2022 | 7.617M |
| September 30, 2022 | 4.46M |
| June 30, 2022 | 5.139M |
| March 31, 2022 | 6.219M |
| December 31, 2021 | 5.443M |
| September 30, 2021 | 3.635M |
| June 30, 2021 | 3.118M |
| March 31, 2021 | 3.768M |
| December 31, 2020 | 3.543M |
| September 30, 2020 | 2.775M |
| June 30, 2020 | 2.593M |
| March 31, 2020 | 2.596M |
| December 31, 2019 | 3.611M |
| September 30, 2019 | 3.225M |
| June 30, 2019 | 3.733M |
| March 31, 2019 | 3.955M |
| December 31, 2018 | 4.551M |
| September 30, 2018 | 4.109M |
| June 30, 2018 | 4.106M |
| March 31, 2018 | 4.382M |
| December 31, 2017 | 4.237M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.393M |
| June 30, 2017 | 4.447M |
| March 31, 2017 | 4.255M |
| December 31, 2016 | 5.389M |
| September 30, 2016 | 5.711M |
| June 30, 2016 | 5.715M |
| March 31, 2016 | 5.562M |
| December 31, 2015 | 5.929M |
| September 30, 2015 | 5.449M |
| June 30, 2015 | 6.688M |
| March 31, 2015 | 8.328M |
| December 31, 2014 | 7.699M |
| September 30, 2014 | 6.987M |
| June 30, 2014 | 8.021M |
| March 31, 2014 | 8.81M |
| December 31, 2013 | 7.497M |
| September 30, 2013 | 8.978M |
| June 30, 2013 | 6.579M |
| March 31, 2013 | 7.252M |
| December 31, 2012 | 9.335M |
| September 30, 2012 | 7.297M |
| June 30, 2012 | 6.746M |
| March 31, 2012 | 6.802M |
| December 31, 2011 | 6.498M |
| September 30, 2011 | 5.935M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.593M
Minimum
Jun 2020
8.20M
Maximum
Sep 2023
4.848M
Average
3.768M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
| Corvus Pharmaceuticals Inc | 6.869M |
| Oragenics Inc | 1.798M |
| Relmada Therapeutics Inc | 12.19M |
| Alpine Immune Sciences Inc | 51.91M |
| MAIA Biotechnology Inc | 7.089M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.805M |
| Shareholders Equity (Quarterly) | 0.607M |
| Current Ratio | 0.9121 |